STOCK TITAN

LakeShore Biopharma Co (LSBCF) Revenue by Year

LSBCF

LakeShore Biopharma Co generated $85.7M in revenue in fiscal year 2025. This represents an increase of 6.0% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters LakeShore Biopharma Co has filed alongside them.

FY2025 annual
Revenue $85.7M
YoY +6.0%
Source SEC Filings Latest period FY2025, ended Mar 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LSBCF Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21Filing
Revenue$85.7M+6.0%$80.8M-19.2%$100.0M+26.0%$79.3M+102.2%$39.2M

LSBCF Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'25FilingQ4'24FilingQ4'23FilingQ4'22Filing
RevenueN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More LakeShore Biopharma Co financials

Frequently Asked Questions

LakeShore Biopharma Co generated $85.7M in revenue in fiscal year 2025.

LakeShore Biopharma Co (LSBCF) revenue rose by 6.0% year over year, from $80.8M to $85.7M in fiscal year 2025.

Across the 5 fiscal years this page covers, LakeShore Biopharma Co (LSBCF) revenue went from $39.2M in fiscal year 2021 to $85.7M in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what LakeShore Biopharma Co (LSBCF) reported on that line in every period on record.